omega-n-methylarginine has been researched along with nitroaspirin in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (nitroaspirin) | Trials (nitroaspirin) | Recent Studies (post-2010) (nitroaspirin) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 127 | 9 | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berti, F; Del Soldato, P; Manfredi, B; Rossoni, G | 1 |
1 other study(ies) available for omega-n-methylarginine and nitroaspirin
Article | Year |
---|---|
NCX 4016, a nitric oxide-releasing aspirin, modulates adrenergic vasoconstriction in the perfused rat tail artery.
Topics: Animals; Arteries; Aspirin; Cyclic GMP; Dose-Response Relationship, Drug; Electric Stimulation; Male; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Perfusion; Rats; Rats, Wistar; Tail; Vasoconstriction | 2002 |